OClawVPS.com
Eumentis Therapeutics
Edit

Eumentis Therapeutics

https://www.eumentistx.com/
Last activity: 29.05.2024
Active
Categories: ScienceTechnology
Integrating the best of clinically validated science and leading-edge technology to improve the lives of children and adults with serious, neglected neuropsychiatric conditions.
Mentions
4
Total raised: $40M

Investors 5

Funding Rounds 1

DateSeriesAmountInvestors
15.02.2023Series B$40M-

Mentions in press and media 4

DateTitleDescription
29.05.2024EuMentis Therapeutics’ CMO Randall Marshall to Present on its novel PDE10A inhibitor for Tourette Syndrome at TicCon24Dr. Marshall's Presentation on Friday May 31, 2024 I am pleased to participate in this important event and present our preclinical & phase 1 clinical results, and phase 2 clinical plans on EM-221, our novel PDE10 inhibitor for Tourette ...
15.05.2024EuMentis Therapeutics’ Chief Medical Office Randall Marshall, MD to Give Keynote Presentation at Autism Parenting SummitPresentation on May 19, 2024 at 10:30am edt It is very important to us to work with the autism community as we advance EM-113 into this Phase 2 clinical trial, and I hope this educational presentation will benefit both parents and patients”...
15.02.2023EuMentis Therapeutics Inc. Announces the First Closing of a Targeted $40M Series B Financing to Advance Novel Therapeutics to Treat Autism Spectrum Disorder, Tourette Syndrome and Traumatic Brain Inju...-
08.02.2023EuMentis Therapeutics Inc. Receives $3 Million Award from United States Department of Defense (DoD) to Advance its Novel NMDA Receptor Antagonist for Traumatic Brain Injury-

Reviews 0

Sign up to leave a review

Sign up Log In